NEW · Pharmaceuticals
LLY
Eli Lilly and Co · $1.08T
1,142.85
-0.61%
Price
252 sessions shownTechnicals
from daily closesRSI · 14 day
51.7
Avg true range · 14d
2.73%
Volatility · 20d annualised
19.7%
Trend · 20d vs 50d
Down
vs 20-day average
-0.73%
vs 50-day average
-2.88%
vs 200-day average
6.43%
200-day average
1,073.81
Internals
where it sits, and how hard it is being traded52-week low
783.85
52-week high
1,292.65
Volume vs its 20-day avg
0.90×
Beta vs the market
0.42
Sitting 71% of the way up its 52-week range (783.85 → 1,292.65)
Swings
prices it actually turned at — highest or lowest of the surrounding 11 sessionsTurned down · Jul 7
1,249.45
Turned down · Jul 28
1,232.00
Turned down · Aug 19
1,292.65
Turned up · Aug 3
1,109.15
Turned up · Aug 17
1,163.50
Turned up · Sep 11
1,113.29
Fundamentals
P/E
40.28
Fwd P/E
—
P/S
13.50
P/B
38.29
EV/EBITDA
31.39
ROE
92.6%
ROA
22.0%
Gross margin
83.4%
Net margin
—
Debt / equity
1.60
Rev growth
49.6%
EPS growth
49.3%
Earnings
Next report
Oct 29, 2026
EPS expected
10.03
Beat in last 4
4 of 4
2026-06-30reported 8.38 vs 6.07 expected+38.1%
2026-03-31reported 8.55 vs 6.73 expected+27.0%
2025-12-31reported 7.54 vs 6.74 expected+11.9%
2025-09-30reported 7.02 vs 5.75 expected+22.0%
Analyst coverage
38 analysts · as of 2026-09-01Strong buy
11
Buy
19
Hold
7
Sell
1
Strong sell
0
News
stories naming this company, last 21 daysEvery figure here is measured from live market data as of Oct 4, 05:43 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.